Skip to content
World Future UK

Zimbabwe Declines ‘Lopsided’ American Healthcare Assistance Agreement Over Data Concerns

Medical funding illustration
The offered US financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has declined a major American health deal worth 367 million US dollars (£272m) over five years due to Washington's request for sensitive data.

This move was revealed after a internal memorandum from December was disclosed, revealing that President Emmerson Mnangagwa deemed the agreement was "unbalanced".

An official spokesperson later explained that the US was requesting health data for scientific study and commercial gain while was not willing to share the benefits from any future medical innovations.

"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for more dialogue to find a agreement agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.

Broader Background

This rejection comes after a comparable situation in neighbouring Kenya, where a high court halted a similar deal with the US following legal challenges were filed about the security of citizens' medical information.

After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

USAID had managed aid for the American government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government deals to enhance transparency and responsibility.

Based on reports, 16 African countries have so far agreed to these new health pacts, constituting over $18.3bn in committed funds.

Details of the Rejected Agreement

The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this cooperation could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"The proposal required Zimbabwe to share its biological resources and data over an extended period, with no corresponding promise of benefiting from any medical innovations – like new medicines or tests – that could be developed from that shared data," Mangwana explained.

"Effectively, our country would supply the raw materials for scientific discovery with no certainty that the resulting innovations would be accessible to our citizens if a future disease outbreak emerge."

National Interest and Global Health

He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already set up via the international organization.

Mangwana cited its Pandemic Benefit-Sharing system created to manage future pandemics.

"This mechanism is intended to guarantee that when a country contributes its samples, the benefits – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."

These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We welcome continued discussions with our American counterparts on how future co-operation could be designed in a manner that honours the independence and interests of each country."

Health Experts Reaction

A leading public health body expressed it understood the official position, but suggested that negotiations should continue given that a large portion of the country's Aids initiatives were funded by foreign aid.

"In cases where specific concerns exist, such as those involving data governance or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," the group added.

This impasse highlights the ongoing tensions between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly interconnected world.

The writer

Stephanie Jackson

Elara Vance is a tech futurist and innovation strategist with over a decade of experience analyzing global tech trends and their societal implications.

World Future UK

Type to search articles.